Considering TRIP13 induced treatment resistance by interacting with NHEJ proteins KU70/KU80/DNA-PKcs and its inhibitor DCZ0415 impaired NHEJ 15, 19, we speculated that the combination of DCZ0415 and Olaparib increased the inhibition level of HCC. The gene discussed is TRIP13; the disease is hepatocellular carcinoma.